89bio (NASDAQ:ETNB) Rating Reiterated by Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of 89bio (NASDAQ:ETNB – Free Report) in a report issued on Wednesday, Benzinga reports. They currently have a $29.00 price target on the stock. ETNB has been the subject of several other research reports. Royal Bank of Canada lowered their price target on 89bio from $15.00 to […]

Leave a Reply

Your email address will not be published.

Previous post Tonix Pharmaceuticals (NASDAQ:TNXP) Research Coverage Started at StockNews.com
Next post StockNews.com Begins Coverage on U.S. Energy (NASDAQ:USEG)